BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 9315071)

  • 1. Recurrent melanoma of the leg and polypoid lesions of the gallbladder--a management dilemma.
    Gould SW; Banwell PE; Rosin RD
    Eur J Surg Oncol; 1997 Aug; 23(4):368-9. PubMed ID: 9315071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma.
    Noorda EM; Takkenberg B; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Hart GA; Kroon BB
    Ann Surg Oncol; 2004 May; 11(5):491-9. PubMed ID: 15078633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melphalan in regional chemotherapy for locally recurrent metastatic melanoma.
    Defty CL; Marsden JR
    Curr Top Med Chem; 2012; 12(1):53-60. PubMed ID: 22196271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases.
    Deroose JP; Grünhagen DJ; Eggermont AM; Verhoef C
    Melanoma Res; 2015 Oct; 25(5):427-31. PubMed ID: 26110555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic cholecystectomy for polypoid lesions of the gallbladder: a clinicopathologic study.
    Yeh CN; Jan YY; Chao TC; Chen MF
    Surg Laparosc Endosc Percutan Tech; 2001 Jun; 11(3):176-81. PubMed ID: 11444747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic isolated limb perfusion (ILP) in the management of patients with advanced or recurrent limb melanoma.
    Khan MA; Lanitis S; Desai AP; Rosin RD
    Ir J Med Sci; 2012 Mar; 181(1):157. PubMed ID: 21959950
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma recurrence confined to a free flap after isolated limb perfusion.
    Roberts CE; Harris PA; Thomas JM
    J Plast Reconstr Aesthet Surg; 2009 Aug; 62(8):e277-9. PubMed ID: 18463014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure.
    Grünhagen DJ; van Etten B; Brunstein F; Graveland WJ; van Geel AN; de Wilt JH; Eggermont AM
    Ann Surg Oncol; 2005 Aug; 12(8):609-15. PubMed ID: 15968498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
    Takkenberg RB; Vrouenraets BC; van Geel AN; Nieweg OE; Noorda EM; Eggermont AM; Kroon BB
    J Surg Oncol; 2005 Aug; 91(2):107-11. PubMed ID: 16028280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated limb perfusion: what is the evidence for its use?
    Noorda EM; Vrouenraets BC; Nieweg OE; Van Coevorden F; Kroon BB
    Ann Surg Oncol; 2004 Sep; 11(9):837-45. PubMed ID: 15313738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated limb perfusion for an irresectable melanoma recurrence in a Jehovah's witness.
    van Akkooi AC; Golab-Schwarz HD; Eggermont AM; van Geel AN
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):408-10. PubMed ID: 16829108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma.
    Zogakis TG; Bartlett DL; Libutti SK; Liewehr DJ; Steinberg SM; Fraker DL; Alexander HR
    Ann Surg Oncol; 2001 Dec; 8(10):771-8. PubMed ID: 11776490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma.
    Coventry BJ; Kroon HM; Giles MH; Henderson M; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM
    J Surg Oncol; 2014 Jun; 109(8):780-5. PubMed ID: 24634160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic cholecystectomy for a metastasis of a malignant melanoma in the gallbladder.
    Seelig MH; Schönleben K
    Z Gastroenterol; 1997 Sep; 35(9):673-5. PubMed ID: 9360293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics.
    Bartlett DL; Ma G; Alexander HR; Libutti SK; Fraker DL
    Cancer; 1997 Dec; 80(11):2084-90. PubMed ID: 9392330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of isolated limb perfusion to manage recurrent malignant melanoma.
    Ma D; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):441-50, ix. PubMed ID: 10941564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.